J&J Gets CDSCO Panel Nod To Market Teclistamab sterile liquid in Vials Dr. Divya Colin7 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Johnson and Johnson has got approval from the Subject Expert Committee (SEC) functional under...
J&J Gets CDSCO Panel Nod to study anticancer drug Cetrelimab Dr. Divya Colin16 Jun 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Johnson and Johnson has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Submit Additional Safty Data: CDSCO Tells J&J on Ustekinumab solution for injection Dr. Divya Colin29 April 2023 6:00 PM ISTNew Delhi: In response to the drug major Johnson & Johnson's proposal of Ustekinumab solution for injection for additional indication, the Subject...
US judge halts most talc lawsuits against Johnson and Johnson Ruchika Sharma21 April 2023 2:15 PM ISTLTL Management argued that allowing litigation against J&J to continue would imperil current settlement efforts.
Janssen seeks USFDA nod for Niraparib and Abiraterone Acetate Dual-Action Tablet, plus Prednisone to treat patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations Ruchika Sharma2 March 2023 3:15 PM ISTMetastatic castration-resistant prostate cancer characterizes cancer that no longer responds to androgen deprivation therapy and has spread to other...
CDSCO opines J&J to submit details of Anticancer Drug Teclistamab approval in EU, US Dr. Divya Colin15 Dec 2022 6:00 PM ISTNew Delhi: In response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and...
Johnson & Johnson Gets CDSCO Panel Okay To Study Anti-cancer Drug Lazertinib/Amivantamab Dr. Divya Colin4 Nov 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Johnson and Johnson has got green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
JnJ gets CDSCO Panel nod to study antipsychotic drug Paliperidone Palmitate Dr. Divya Colin29 Sept 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard...
Health Bulletin 13/August/2022 Roshni Dhar13 Aug 2022 5:20 PM ISTHere are the top health stories for the day:With strict bond terms, Rajasthan in-service PG medicos facing trouble getting study leaveWith the State...
JnJ to terminate COVID vaccine agreement with Emergent BioSolutions Ruchika Sharma7 Jun 2022 4:33 PM ISTIf the agreement is terminated, Emergent said J&J would owe it roughly $125 million to $420 million.
There is no unmet need: CDSCO Panel rejects J&J proposal to Import and manufacture Paliperidone Palmitate Dr. Divya Colin29 May 2022 11:29 AM ISTNew Delhi: Citing that there is no unmet need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Janssen Pharma launches icare4u program for skin, joint, digestive disorders Ruchika Sharma22 May 2022 9:00 AM ISTMumbai: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the launch of icare4u, a comprehensive program to support the...
